Trusted Press Release Distribution   Join | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Fact.mr
www.factmr.com/
James Jones
info@factmr.com
35316111593
Suite 9884 27 Upper Pembroke Street, Dublin 2


Bookmark and Share
Global Eugenol Market to Reach US$ 754.1 million revenue by 2026 end: Fact.MR’s Report
According to Fact.MR’s recent research report, the global market for eugenol is projected to reflect an impressive 6.0% CAGR, in terms of value, over the forecast period, 2017 to 2026.

BriefingWire.com, 6/14/2018 - The rapidly expanding eugenol market is the focus of a new report added to the market intelligence repository of Fact.MR. This 170-page broad study is headlined as “Eugenol Market Research Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2026” which noticeably examines the prospects of the global eugenol industry till the end of 2022, using the market’s development trajectory in the recent past as the key indicator of actionable insights into the market’s growth pattern. A blend of primary & secondary research has been implemented for offering estimates and forecasts on the concerned market.

Request Sample Report@ www.factmr.com/connectus/sample?flag=S&rep_id=513

Eugenol to Seek Significant Adoption as Potential Chemotherapeutic Agent

Predominantly sought in spices including basil, cinnamon, clove and nutmeg, eugenol comprises potent anti-stress and neuro-protective properties. In light of these properties, eugenol hold potential of inhibiting transmission in sciatic nerves, and improving neuronal complications. In addition, novel strategies implemented in cancer prevention have initiated utilization of eugenol as one of the potential chemotherapeutic agent. Synergistic effect of eugenol combined with chemo-preventive drugs significantly help in reducing drug toxicity in normal cells, meanwhile augmenting cytotoxicity of synthetic agents. Inhibitory action of eugenol & iso-eugenol have been suggested against melanoma cell lines, as it induces apoptosis and leads to cell cycle arrest, thereby curtailing cell proliferation in cancer patients.

APEJ to Remain Dominant in Global Eugenol Market

In terms of value, Asia-Pacific excluding Japan (APEJ) is slated to remain dominant in the global eugenol market. Dominance of APEJ in the market can be mainly attributed to surging prevalence of ailments such as diabetes, and cancer. In addition, the region exhibits a significant surge in geriatric population, which is highly prone to these diseases. North America is also expected to remain a remunerative region for the eugenol market, on the back of its technological and economic vigour.

Revenues from end-use of eugenol in personal care products is forecast to record the fastest expansion through 2026. Numerous unapproved OTC products exist in the market with eugenol as an integral compound for preventing and treating toothache. In addition, eugenol is commonly employed in dental procedures along with zinc oxide for cementation of temporary prostheses.

Competition Tracking

Eugenol derivatives have unlocked a whole new opportunity in the field of pharmacology, kindling interests of leading market players on this compound. These players are making R&D investments for coming up with specifications for identifying dosage of eugenol required for functional applications, and exploring hidden potentials of eugenol in improving human health. Key players that Fact.MR’s report expects to drive growth of the global eugenol market include Van Aroma, Nile Chemicals, Sigma-Aldrich, Nusaroma Indonesia Essential Oil, Berjé, CV. Indaroma, Extrasynthese, Penta Manufacturing Company, Vigon International, and Boc Sciences.

View Report@ www.factmr.com/report/513/eugenol-market

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2013 Proserve Technology, Inc.